According to the ETF Finder at ETF Channel, INCY makes up 2.53% of the Dynamic Biotechnology & Genome Portfolio ETF (PBE) which is higher by about 1.4% on the day Thursday.
In afternoon trading Thursday, INCY was up about 5.1% on the day.
Pfizer (PFE) has agreed to acquire Medivation (MDVN) for $14 billion, fueling speculation of a future deal with Incyte (INCY).
Barclays increased its price target to $100 on Incyte (INCY) stock this morning.
The company's share price despite reporting better-than-expected earnings and revenue and